ENRIQUE HERRERA ACOSTA – ENSAYO CLÍNICO CON MEDICAMENTOS – LEO PHARMA A/S
Adjustable brodalumab dosage regimen compared with standard brodalumab treatment for 52 weeks in subjects with moderate-to-severe plaque psoriasis and =120 kg body weight
by prodriguez | Jul 3, 2024 | Clinical Trials, Ensayos Clínicos - B-10 | 0 comments